Hope, Quality of Life, and Benefit From Treatment in Women Having Chemotherapy for Platinum-Resistant/Refractory Recurrent Ovarian Cancer: The Gynecologic Cancer Intergroup Symptom Benefit Study
Open Access
- 9 October 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in The Oncologist
- Vol. 18 (11) , 1221-1228
Abstract
Learning Objectives: Explain the connection between depression and unrealistic expectations of the benefits of palliative therapy. Distinguish the trait of general hopefulness from hope for a specific favorable outcome.Keywords
Funding Information
- Australian National Health and Medical Research Council (APP570893)
- Ovarian Cancer Research Foundation
This publication has 46 references indexed in Scilit:
- Patients' Expectations about Effects of Chemotherapy for Advanced CancerNew England Journal of Medicine, 2012
- Using scenarios to explain life expectancy in advanced cancer: attitudes of people with a cancer experienceSupportive Care in Cancer, 2012
- Associations Between End-of-Life Discussions, Patient Mental Health, Medical Care Near Death, and Caregiver Bereavement AdjustmentJAMA, 2008
- Patient–oncologist communication in advanced cancer: predictors of patient perception of prognosisSupportive Care in Cancer, 2008
- Ovarian cancer: a focus on management of recurrent diseaseNature Clinical Practice Oncology, 2006
- Why Do Patients Choose Chemotherapy Near the End of Life? A Review of the Perspective of Those Facing Death From CancerJournal of Clinical Oncology, 2006
- The Perils of HopeCambridge Quarterly of Healthcare Ethics, 2005
- Abbreviated instrument to measure hope: development and psychometric evaluationJournal of Advanced Nursing, 1992
- A power primer.Psychological Bulletin, 1992
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983